Nucleus_Commercial_Financ - Accounts


Nucleus Commercial Finance Limited
Annual Report and Financial Statements
For the year ended 31 March 2021
Company Registration No. 07829566 (England and Wales)
Nucleus Commercial Finance Limited
Company Information
Directors
C Shah
M Goldman
S Willmett
Secretary
G May
Company number
07829566
Registered office
Mezzanine Floor
St Albans House
57-59 Haymarket
London
SW1Y 4QX
Auditor
Moore Kingston Smith LLP
Devonshire House
60 Goswell Road
London
EC1M 7AD
Nucleus Commercial Finance Limited
Contents
Page
Directors' report
1 - 2
Independent auditor's report
3 - 6
Profit and loss account
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 13
Nucleus Commercial Finance Limited
Directors' Report
For the year ended 31 March 2021
Page 1

The directors present their annual report and financial statements for the year ended 31 March 2021.

Principal activities

The principal activity of the company continued to be the provision of invoice factoring.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

C Shah
M Goldman
S Willmett
Auditor

The auditor, Moore Kingston Smith LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Nucleus Commercial Finance Limited
Directors' Report (Continued)
For the year ended 31 March 2021
Page 2
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
S Willmett
Director
29 September 2021
Nucleus Commercial Finance Limited
Independent Auditor's Report
To the Members of Nucleus Commercial Finance Limited
Page 3
Opinion

We have audited the financial statements of Nucleus Commercial Finance Limited (the 'company') for the year ended 31 March 2021 which comprise the Profit And Loss Account, the Balance Sheet, the Statement of Changes in Equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 March 2021 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 4

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report and take advantage of the small companies exemption from the requirement to prepare a Strategic Report.

Responsibilities of directors

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 5

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Our approach was as follows:

  • We obtained an understanding of the legal and regulatory requirements applicable to the company and considered that the most significant are the Companies Act 2006, UK financial reporting standards as issued by the Financial Reporting Council, Financial Conduct Authority regulation and UK taxation legislation.

  • We obtained an understanding of how the company complies with these requirements by discussions with management and those charged with governance.

  • We assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance.

  • We inquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations.

  • Based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required.

 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the company’s internal control.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.

  • Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.

  • Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 6
Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken for no purpose other than to draw to the attention of the company’s members those matters we are required to include in an auditor's report addressed to them. To the fullest extent permitted by law, we do not accept or assume responsibility to any party other than the company and the company’s members as a body, for our work, for this report, or for the opinions we have formed.

Ryan Day (Senior Statutory Auditor)
for and on behalf of Moore Kingston Smith LLP
29 September 2021
Chartered Accountants
Statutory Auditor
Devonshire House
60 Goswell Road
London
EC1M 7AD
Nucleus Commercial Finance Limited
Profit and Loss Account
For the year ended 31 March 2021
Page 7
2021
2020
£
£
Turnover
1,953,963
1,894,141
Cost of sales
(173,628)
(249,636)
Gross profit
1,780,335
1,644,505
Administrative expenses
(318,814)
(863,371)
Operating profit
1,461,521
781,134
Interest payable and similar expenses
(1,175,170)
(1,183,889)
Profit/(loss) before taxation
286,351
(402,755)
Taxation
-
0
76,532
Profit/(loss) for the financial year
286,351
(326,223)
Total comprehensive income for the year
286,351
(326,223)
Nucleus Commercial Finance Limited
Balance Sheet
As at 31 March 2021
31 March 2021
Page 8
2021
2020
Notes
£
£
£
£
Current assets
Debtors
3
6,922,491
11,178,570
Cash at bank and in hand
4,838,643
3,142,960
11,761,134
14,321,530
Creditors: amounts falling due within one year
4
(5,548,776)
(5,039,051)
Net current assets
6,212,358
9,282,479
Creditors: amounts falling due after more than one year
5
(5,462,906)
(7,819,378)
Net assets
749,452
1,463,101
Capital and reserves
Called up share capital
6
100,000
100,000
Profit and loss reserves
649,452
1,363,101
Total equity
749,452
1,463,101

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 29 September 2021 and are signed on its behalf by:
S Willmett
Director
Company Registration No. 07829566
Nucleus Commercial Finance Limited
Statement of Changes in Equity
For the year ended 31 March 2021
Page 9
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2019
100,000
7,289,324
7,389,324
Year ended 31 March 2020:
Loss and total comprehensive income for the year
-
(326,223)
(326,223)
Dividends
-
(5,600,000)
(5,600,000)
Balance at 31 March 2020
100,000
1,363,101
1,463,101
Year ended 31 March 2021:
Profit and total comprehensive income for the year
-
286,351
286,351
Dividends
-
(1,000,000)
(1,000,000)
Balance at 31 March 2021
100,000
649,452
749,452
Nucleus Commercial Finance Limited
Notes to the Financial Statements
For the year ended 31 March 2021
Page 10
1
Accounting policies
Company information

Nucleus Commercial Finance Limited is a private company limited by shares domiciled and incorporated in England and Wales. The registered office is Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX.

1.1
Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

As at 31 March 2021, the company had net assets of £749,452 and generated a profit of £286,351 for the year ended 31 March 2021. The company is a subsidiary of Nucleus Commercial Holdings Limited. As at 31 March 2021, the group had net assets of £7,057,939 and made a loss of £1,792,041 for the year ended 31 March 2021. The group is funded through long-term credit facilities with third party lenders and the amount owed at 31 March 2021 was £237,169,948. The Directors have confirmed that the profitable entities generating surplus cash will continue to support the loss-making entities within the group, for at least one year from the date of approval of the accounts. As such the accounts have been prepared on a going concern basis.  true

 

In March 2020 the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a global health pandemic, which spread globally and throughout the UK. Global markets and economies experienced a significant amount of volatility as a result of the pandemic. As at 31 March 2020 it was expected the disruption would be temporary and there was uncertainty around the duration, future cash flows and debtor recoverability. In light of the events over the past year, as at 31 March 2021 the related financial impact of this matter still cannot be reasonably estimated, though it has created financial opportunities for the group in light of the Coronavirus Business Interruption Loan Scheme (CBILS) introduced by the UK government. As a result, the directors do not believe the pandemic will have material negative impact on the business. This continues to be an area of active management focus in respect of adjusted actions or investments that may become commercially prudent and the position is being reviewed on a regular basis.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Factoring charge revenue is recognised monthly dependent on the value of the client's facility. Take on fees are accrued at the point of the start of the contract with the client. Commitment fees relate to preliminary work carried out to establish the risk profile of the client which are then recharged and are accrued as invoiced. Early exit fees are recognised upon the early termination of a contract. As such there is no material revenue which is subject to the stage of completion of a contract.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2021
1
Accounting policies
(Continued)
Page 11
1.4
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.

1.5
Financial instruments

Basic financial instruments are measured at cost. The company has no other financial instruments or basic financial instruments measured at fair value.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable, and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

 

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2021
Page 12
2
Employees

There were no persons employed by the company during the year or the comparative period.

3
Debtors
2021
2020
Amounts falling due within one year:
£
£
Trade debtors
6,296,183
9,373,283
Corporation tax recoverable
76,523
76,523
Amounts due from group undertakings
549,785
1,590,010
Other debtors
-
0
138,754
6,922,491
11,178,570

Included within trade debtors is an amount of £730,562 (2020: £4,717,108) which is due after more than one year, gross of the bad debt provision.

4
Creditors: amounts falling due within one year
2021
2020
£
£
Trade creditors
2,072,289
150,760
Amounts due to group undertakings
17,844
79,799
Other taxation and social security
96,970
92,530
Other creditors
3,361,673
4,715,962
5,548,776
5,039,051

Included in other creditors falling due within one year is £3,249,342 (2020: £4,573,569) loan secured by fixed and floating charges over the company's current assets.

5
Creditors: amounts falling due after more than one year
2021
2020
£
£
Other creditors
5,462,906
7,819,378

Included in other creditors due after more than one year is £5,462,906 (2020: £7,819,378) loan secured by fixed and floating charges over the company's current assets.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2021
Page 13
6
Called up share capital
2021
2020
£
£
Ordinary share capital
Issued and fully paid
10,000,000 Ordinary shares of 1p each
100,000
100,000
100,000
100,000

 

7
Related party transactions

The company has taken advantage of the exemption available in accordance with FRS 102 section 33 'Related Party Disclosures' not to disclose transactions entered into between two or more members of a group, as the company is a wholly owned subsidiary undertaking of the group with which it is party to the transactions.

8
Control

The parent company of Nucleus Commercial Finance Limited is Nucleus Commercial Holdings Limited, a company incorporated in England and Wales who prepare consolidated accounts for the group. Copies of the consolidated accounts are available from Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX.

 

The ultimate parent undertaking is Nucleus Holdings Limited, a company incorporated in Isle of Man.

2021-03-312020-04-01falseCCH SoftwareCCH Accounts Production 2021.300C ShahM GoldmanS WillmettG May0078295662020-04-012021-03-3107829566bus:Director12020-04-012021-03-3107829566bus:Director62020-04-012021-03-3107829566bus:Director82020-04-012021-03-3107829566bus:CompanySecretary12020-04-012021-03-3107829566bus:Director22020-04-012021-03-3107829566bus:Director32020-04-012021-03-31078295662021-03-31078295662019-04-012020-03-31078295662020-03-3107829566core:CurrentFinancialInstruments2021-03-3107829566core:CurrentFinancialInstruments2020-03-3107829566core:Non-currentFinancialInstruments2021-03-3107829566core:Non-currentFinancialInstruments2020-03-3107829566core:ShareCapital2021-03-3107829566core:ShareCapital2020-03-3107829566core:RetainedEarningsAccumulatedLosses2021-03-3107829566core:RetainedEarningsAccumulatedLosses2020-03-3107829566core:ShareCapitalcore:RestatedAmount2019-03-3107829566core:RetainedEarningsAccumulatedLossescore:RestatedAmount2019-03-3107829566core:RestatedAmount2019-03-3107829566core:ShareCapitalOrdinaryShares2021-03-3107829566core:ShareCapitalOrdinaryShares2020-03-3107829566core:RetainedEarningsAccumulatedLosses2019-04-012020-03-3107829566bus:OrdinaryShareClass12020-04-012021-03-3107829566bus:OrdinaryShareClass12021-03-3107829566bus:PrivateLimitedCompanyLtd2020-04-012021-03-3107829566bus:FRS1022020-04-012021-03-3107829566bus:Audited2020-04-012021-03-3107829566bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP